Follow
Personalized RNA #vaccines for #melanoma advance to phase III trials (in combination with anti-PD1).
My latest Clinical Pipeline column for @NatureMedicine #Immunology #Immunotherapy
https://www.nature.com/articles/d41591-023-00072-0
@cyrilpedia
your article should be free!!!